[ Price : $8.95]
CDRH patient safety senior advisor Jay Crowley retires from FDA to join regulatory consulting firm USDM Life Sciences as vice pres...[ Price : $8.95]
FDA approves Baxters Feiba indicated for preventing or reducing the frequency of bleeding episodes in patients with hemophilia A o...[ Price : $8.95]
Amgen reports that its Phase 3 DESCARTES study of evolocumab in patients with high cholesterol met its primary endpoint of percent...[ Price : $8.95]
FDA approves an Xlumena de novo petition for the AXIOS Stent and Delivery System for treating pseudocysts that form in the pancrea...[ Price : $8.95]
Attorneys writing the Drug and Device Law blog urge drug and medical device companies to argue federal preemption of off-label saf...[ Price : $8.95]
Sandoz initiates a Phase 3 study of its biosimilar version of AbbVies Humira.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on testing commun...[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 3/28/14: FDA/American Academy of Ophthalmology (AAO) Workshop on Developing N...